KKR co-founder Henry Kravis at Trump Tower. Photo by Drew Angerer/Getty Images

Private equity firm KKR this morning announced a deal to buy BMC Software from Bain Capital and Golden Gate Capital.

Bottom line: Expect BMC to soon begin buying up smaller enterprise software companies. As a source says: "It will probably become an acquisition engine again."

  • No terms were disclosed. We hear the price was below the $10 billion figure that has been bandied about, but well above the $6.9 billion that Bain and GGC paid to take BMC private five years ago.
  • Bain and GGC had previously tried to buy CA and then merge it with BMC, but ran into financing troubles. Rival bidder Thoma Bravo reportedly wanted to merge BMC with existing portfolio company Compuware.
  • KKR plans to go it alone, but don't be surprised if it ramps up the add-on acquisition engine (something BMC was famous for prior to its take-private). Nothing specific is baked into the deal, however.
  • In terms of organic growth, a source says that KKR believes Bain and GGC focused primarily on product, and that it can capitalize on available go-to-market.

Go deeper

Updated 6 mins ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 2 p.m. ET: 12,118,667 — Total deaths: 551,271 — Total recoveries — 6,649,930Map.
  2. U.S.: Total confirmed cases as of 2 p.m. ET: 3,081,383 — Total deaths: 132,570 — Total recoveries: 953,420 — Total tested: 37,431,666Map.
  3. Public health: Cases rise in 33 statesFlorida reports highest single-day coronavirus death toll since pandemic began.
  4. Science: World Health Organization acknowledges airborne transmission of coronavirus.
  5. Travel: Young adults are most likely to have moved due to coronavirus.
23 mins ago - World

China's extraterritorial threat

Illustration: Aïda Amer/Axios

All multinational companies and executives need to worry about breaking U.S. law, no matter where they're based or doing business. Now, they need to worry about Chinese law, too.

Why it matters: The projection of U.S. norms and laws around the world has been an integral (and much resented) part of America's "soft power" since 1945. As China positions itself to replace the USA as global hegemon, expect it to become increasingly assertive along similar lines.

Big Pharma launches $1B venture to incentivize new antibiotics

Illustration: Lazaro Gamio/Axios

A group of large drug companies launched a $1 billion AMR Action Fund Thursday in collaboration with policymakers, philanthropists and development banks to push the development of two to four new antibiotics by 2030.

Why it matters: Antimicrobial resistance (AMR) is a growing problem — possibly killing up to 20 million people annually by 2050 — but a severe lack of R&D market incentives has hampered efforts to develop a robust antibiotic pipeline to address the issue.